Tech Company Financing Transactions
SomaLogic Funding Round
Mitsui & Co. Venture Partners participated in a $19.5 million Series C venture round for SomaLogic. The round was announced on 2/20/2003.
Transaction Overview
Company Name
Announced On
2/20/2003
Transaction Type
Venture Equity
Amount
$19,500,000
Round
Series C
Investors
Proceeds Purpose
SomaLogic intends to use the proceeds to support its ongoing research and development activities, which focus on commercializing aptamer-based protein microarrays for research applications and ultimately clinical diagnostics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2945 Wilderness Pl.
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
SomaLogic, Inc. is developing novel proteomics systems and applications based on its proprietary aptamer technology. Aptamers are single-stranded DNA and RNA molecules that, like antibodies, can bind to target molecules with high affinity and specificity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roy Smythe
Chief Medical Officer
Stephen Williams
Chief Operating Officer
Alan Williams
Chief Scientific Officer
Nebojsa Janjic
President
Melody Harris
Browse more venture capital transactions:
Prev: 2/20/2003: CopperGate Communications venture capital transaction
Next: 2/21/2003: Force10 Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs